NCT00185510View on ClinicalTrials.gov

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

June 30, 2006

Conditions
Dermatitis, Atopic
Interventions
DRUG

Methylprednisolone Aceponate (Advantan, BAY86-4862)

In maintenance phase, Methylprednisolone Aceponate cream is applied topically twice a week.

DRUG

Placebo

2 days a week Vehicle (Advabase)

Sponsors

Lead Sponsor

LEO Pharma

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

LEO Pharma

INDUSTRY